Daily Digit: Novartis Raises Outlook - Presented by: The Aol. On Network

$2.3 billion dollars is today's daily digit - that's the reduced estimate Novartis expects as the impact from losing its U.S. patent for Diovan last year. It had previously forecast $2.7 billion as the hit for the best-selling blood pressure drug. But so far it's been spared the full blow of the patent loss as U.S. regulators are yet to approve another generic copycat version of Diovan by a bigger competitor.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
AAPL $ 117.60 1.03 ▼ 0.86%
PBR $ 10.39 0.11 ▼ 1.05%
BAC $ 17.10 0.08 ▼ 0.47%
PBR/A $ 11.02 0.04 ▼ 0.36%
KMI $ 40.75 0.04 ▼ 0.10%
F $ 15.68 0.01 ▲ 0.06%
FB $ 75.63 1.62 ▲ 2.19%
HBAN $ 10.11 0.07 ▼ 0.69%

As of 11/25/2014, 04:15 PM
More Most Active